Related Experiment Video
Updated: Feb 5, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy
Wioletta Olejarz1,2, Dominika Łacheta1,2, Alicja Głuszko2,3
1Department of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland.
Abstract:
Receptor for advanced glycation end-products (RAGE) and toll-like receptors (TLRs) are the key factors indicating a danger to the organism. They recognize the microbial origin pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs). The primary response induced by PAMPs or DAMPs is inflammation. Excessive stimulation of the innate immune system occurs in arterial wall with the participation of effector cells. Persistent adaptive responses can also cause tissue damage and disease. However, inflammation mediated by the molecules innate responses is an important way in which the adaptive immune system protects us from infection. The specific detection of PAMPs and DAMPs by host receptors drives a cascade of signaling that converges at nuclear factor-κB (NF-κB) and interferon regulatory factors (IRFs) and induces the secretion of proinflammatory cytokines, type I interferon (IFN), and chemokines, which promote direct killing of the pathogen. Therefore, signaling of these receptors' pathways also appear to present new avenue for the modulation of inflammatory responses and to serve as potential novel therapeutic targets for antiatherosclerotic therapy.
Insights
Receptor for advanced glycation end-products (RAGE) and toll-like receptors (TLRs) detect danger signals, initiating inflammation. Targeting these innate immune pathways offers potential anti-atherosclerotic therapies.
Area of Science:
- Immunology
- Molecular Biology
- Cardiovascular Research
Background:
- Receptor for advanced glycation end-products (RAGE) and toll-like receptors (TLRs) are crucial in detecting danger signals.
- These receptors recognize pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), triggering innate immune responses like inflammation.
Purpose of the Study:
- To explore the role of RAGE and TLRs in innate immune activation and inflammation.
- To investigate the therapeutic potential of targeting RAGE and TLR signaling pathways in anti-atherosclerotic therapy.
Main Methods:
- The study focuses on the signaling cascades initiated by PAMPs and DAMPs.
- Analysis of the convergence of these pathways at nuclear factor-κB (NF-κB) and interferon regulatory factors (IRFs).
Main Results:
- RAGE and TLR activation leads to the secretion of proinflammatory cytokines, type I interferon (IFN), and chemokines.
- This signaling cascade is essential for pathogen clearance but can contribute to tissue damage in conditions like atherosclerosis.
Conclusions:
- Inflammation mediated by RAGE and TLRs is a critical component of the immune system's defense against infection.
- Modulating these receptor pathways presents a promising therapeutic strategy for treating inflammatory diseases, including atherosclerosis.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Key Techniques in Microbiology
Key Elements for Plant Nutrition
Gene Therapy
Group Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

